MICROLET NEXT lancing device, MICROLET Lancet— 510(k) K220633

Substantially Equivalent

Ascensia Diabetes Care U.S., Inc.

FDA 510(k) clearance K220633 for MICROLET NEXT lancing device, MICROLET Lancet, Substantially Equivalent on 2022-06-03. Applicant: Ascensia Diabetes Care U.S., Inc..

Clearance details

Applicant
Ascensia Diabetes Care U.S., Inc.
Product code
Code QRL
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Parsippany, NJ, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code QRL

product code QRL
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.